Targeting Bacterial and Human Levodopa Decarboxylases for Improved Drug Treatment of Parkinson's Disease: Discovery and Characterization of New Inhibitors

帕金森病 左旋多巴 药物发现 药品 药理学 疾病 医学 生物 生物信息学 内科学
作者
Saku Reunanen,Léo Ghemtio,Jayvadan K. Patel,Rakesh Patel,Kerttu Airavaara,Jari Yli‐Kauhaluoma,Michael Jeltsch,Henri Xhaard,Petteri Piepponen,Päivi Tammela
出处
期刊:European Journal of Pharmaceutical Sciences [Elsevier BV]
卷期号:: 107133-107133
标识
DOI:10.1016/j.ejps.2025.107133
摘要

Parkinson's disease (PD) is a common neurodegenerative disease, typically treated with levodopa, which alleviates the motor symptoms of the disease. However, levodopa metabolism in peripheral tissues hampers its bioavailability and leads to undesired side-effects. Therefore, co-administration of amino acid decarboxylase (AADC) inhibitors is necessary, but still, up to 50% of levodopa may not reach the brain. Recent evidence suggests that gut microbes, especially Enterococcus faecalis, are also able to metabolize levodopa and affect the bioavailability by utilizing microbial tyrosine decarboxylase (TyrDC) enzyme. The main aim of this study was to develop inhibitors targeting gut microbial and host decarboxylation of levodopa. First, a virtual screen of a library of 158,000 compounds against E. faecalis TyrDC was conducted, combining three methods: molecular docking against the E. faecalis TyrDC homology model, structure-based pharmacophore model, and shape similarity searches based on levodopa, carbidopa (AADC inhibitor) and (S)-α-fluoromethyltyrosine (TyrDC inhibitor). A total of 394 compounds were selected and tested in vitro by using a cell-based E. faecalis assay measuring inhibition of levodopa metabolism. Three most active compounds (49-92% inhibition at 100 µM) sharing a similar scaffold and a set of commercially available and in-house synthesized analogs were then assessed against purified TyrDC and AADC enzymes. The IC50 values for the most potent compounds for TyrDC and AADC inhibition were 23 µM / 144 µM (compound 1), 42 µM / 199 µM (compound 2) and 51 µM / 182 µM (compound 3), respectively. These compounds also displayed cytotoxic effects on HeLa cells and modest antibacterial activity against E. faecalis at the same concentration range. The core structure of the compounds presented here can serve as a starting point for the development of a new inhibitor class against TyrDC and AADC, and offers a promising avenue for personalized PD treatment, particularly for patients with high levels of gut microbes expressing the levodopa metabolizing TyrDC enzyme.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Tony发布了新的文献求助20
刚刚
Jasper的应助被飘逸的苡采纳,获得10
刚刚
蔚雨发布了新的文献求助10
刚刚
1秒前
天天发布了新的文献求助10
2秒前
健康的可仁完成签到,获得积分10
3秒前
cdercder的应助被老九采纳,获得10
3秒前
xiaolizi发布了新的文献求助10
3秒前
4秒前
W_J_J发布了新的文献求助10
4秒前
5秒前
5秒前
孙士淼完成签到 ,获得积分10
6秒前
molihuakai的应助被刘欣宇采纳,获得10
6秒前
6秒前
6秒前
科研通AI65的应助被萧小五采纳,获得10
6秒前
烟花的应助被科研助理795采纳,获得10
7秒前
丘比特的应助被不想上班采纳,获得10
7秒前
7秒前
xingyueli完成签到,获得积分10
7秒前
TGM_Hedwig完成签到,获得积分10
8秒前
8秒前
脑洞疼的应助被DADA采纳,获得10
8秒前
kinji完成签到,获得积分10
8秒前
蒋博芳发布了新的文献求助10
8秒前
Smile发布了新的文献求助20
10秒前
Luka完成签到,获得积分10
10秒前
Owen的应助被WN采纳,获得10
11秒前
xingyueli发布了新的文献求助10
11秒前
所所的应助被积极的黑猫采纳,获得10
11秒前
啊啊啊啊发布了新的文献求助10
11秒前
任性小凡完成签到,获得积分10
11秒前
12秒前
13秒前
gq100520发布了新的文献求助10
14秒前
永无完成签到,获得积分10
14秒前
墨白发布了新的文献求助10
15秒前
15秒前
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193425
求助须知:如何正确求助?哪些是违规求助? 9579620
关于积分的说明 21866505
捐赠科研通 7793025
什么是DOI,文献DOI怎么找? 3437297
关于科研通互助平台的介绍 2560718
邀请新用户注册赠送积分活动 2484128